745836-32-2

Usage

Uses

Used in Neurological Applications:
Benzatropine is used as an anticholinergic agent for the treatment of Parkinson's disease and Parkinson-like symptoms caused by certain medications. It helps to alleviate tremors, muscle stiffness, and other movement disorders by blocking the action of acetylcholine in the brain.
Used in Pharmaceutical Formulations:
Benzatropine is utilized in the development of various pharmaceutical formulations, such as tablets and injections, to provide effective symptom management for patients with Parkinson's disease. It is often combined with other medications to enhance the overall therapeutic effect and improve the quality of life for individuals suffering from movement disorders.
Used in Symptom Management:
Benzatropine serves as a crucial component in the symptom management of Parkinson's disease, where it helps to reduce the severity and frequency of tremors, muscle stiffness, and other movement-related issues. Its use in combination with other medications allows for a more comprehensive approach to managing the symptoms and improving the patient's overall well-being.

InChI:InChI=1/C16H21NO2/c1-2-19-16(18)15-13-8-9-14(15)17(11-13)10-12-6-4-3-5-7-12/h3-7,13-15H,2,8-11H2,1H3

Upstream product

• 112375-05-0 N-benzyl-2-azanorborn-5-ene 
• 64-17-5 ethanol 
• 258264-42-5 3-bromo-1-benzyl-1-azoniatricyclo[2.2.1.0^2,6]heptane bromide 
• 745836-30-0 anti-7-cyano-2-benzyl-2-azabicyclo[2.2.1]heptane 
• 312955-00-3 anti-7-bromo-2-benzyl-2-azabicyclo[2.2.1]heptane 

Relevant academic research and scientific papers

7-Substituted 2-Azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn- and anti-Isoepiboxidine

Neighboring group participation by the 2-nitrogen in anti-7-bromo-2-benzyl- 2-azabicyclo[2.2.1]heptane allows ready nucleophilic substitution at the 7-position by C, N, O, and halogen nucleophiles and opens the way to a range of novel 7-substituted 2-azab